Gomeisa Labs Nolvadex delivers 20 mg of Tamoxifen Citrate per tablet, supplied as 50 tablets in a blister pack. The oral form and blister presentation keep each tablet sealed until use, a format common across products where consistent dosage per unit matters. Gomeisa Labs, a USA-based company making these since 2021, packages this product in a format that matches what many buyers compare when selecting a tamoxifen manufacturer.

20 mg Tamoxifen Citrate Tablets in a 50-Count Blister

Each tablet carries 20 mg of Tamoxifen Citrate, and the blister holds 50 tablets. That count and strength sit in the middle of the range: some listings offer 30 tablets at 20 mg, others package 60 at 10 mg. The blister format protects each tablet individually, and the 50-count pack gives a quantity that covers extended use without requiring multiple orders. The oral form is the standard delivery method for Tamoxifen Citrate across all brands listed in the tamoxifen category.

Gomeisa Labs Nolvadex Beside Other Anti Estrogen Options

This product sits alongside other options in anti estrogen therapy, where buyers compare Tamoxifen Citrate products against Anastrozole and Letrozole listings by strength, count and pack format. Gomeisa Labs offers this at 20 mg per tablet in a 50-tablet blister, where competing listings from other manufacturers present the same substance at identical strength but in different counts—some 30, some 60. The choice between manufacturers often comes down to preferred pack size and whether a buyer values the blister format over bottles or sachets. All three substances in this category differ in mechanism, so cross-substance comparison belongs in guides rather than on this page.